Influenza virus neuraminidase (NA) drug resistance is one of the challenges to preparedness against epidemic and pandemic influenza virus infections.NA N1-and N2-containing influenza viruses are the primary cause of seasonal epidemics and past pandemics.The structural and functional basis underlying drug resistance of the influenza virus N1 NA is well characterized.Yet drug resistance of the N2 strain is not well understood.Here, we confirm that replacement of N2 E119 or I222 results in multidrug resistance, and when the replacements occur together, the sensitivity to NA inhibitors (NAI) is reduced severely.Using crystallographic studies, we showed that E119 replacement results in a loss of hydrogen bonding to oseltamivir and zanamivir,whereas I222 replacement results in a change in the hydrophobic environment that is critical for oseltamivir binding.Moreover,we found that MS-257, a zanamivir-oseltamivir hybrid inhibitor, is less susceptible to drug resistance.The binding mode of MS-257 shows that increased hydrogen bonding interactions between the inhibitor and NA active site anchor the inhibitor within the active site and allow adjustments in response to active-site modifications.Such stability is likely responsible for the observed reduced susceptibility to drug resistance.MS-257 serves as a next-generation anti-influenza virus drug candidate and serves also as a scaffold for further design of NAIs.
Yan Wu Feng Gao Jianxun Qi Yuhai Bi Lifeng Fu Sankar Mohan Yuhang Chen Xuebing Li B.Mario Pinto Christopher J.Vavricka Po Tien George F.Gao
CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Aca Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Aca CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Aca Department of Chemistry, Simon Fraser University, Burnaby, BC, Canad CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Aca
(0)